annual working capital:
$1.22B+$264.80M(+27.81%)Summary
- As of today (May 29, 2025), NBIX annual working capital is $1.22 billion, with the most recent change of +$264.80 million (+27.81%) on December 31, 2024.
- During the last 3 years, NBIX annual working capital has risen by +$490.00 million (+67.40%).
- NBIX annual working capital is now at all-time high.
Performance
NBIX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$1.11B-$102.00M(-8.38%)Summary
- As of today (May 29, 2025), NBIX quarterly working capital is $1.11 billion, with the most recent change of -$102.00 million (-8.38%) on March 31, 2025.
- Over the past year, NBIX quarterly working capital has increased by +$28.90 million (+2.66%).
- NBIX quarterly working capital is now -22.94% below its all-time high of $1.45 billion, reached on September 30, 2024.
Performance
NBIX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
NBIX Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.8% | +2.7% |
3 y3 years | +67.4% | +45.8% |
5 y5 years | +358.0% | +34.7% |
NBIX Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +67.4% | -22.9% | +54.8% |
5 y | 5-year | at high | +358.0% | -22.9% | +104.3% |
alltime | all time | at high | +3335.3% | -22.9% | +5269.1% |
NBIX Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.11B(-8.4%) |
Dec 2024 | $1.22B(+27.8%) | $1.22B(-15.9%) |
Sep 2024 | - | $1.45B(+13.8%) |
Jun 2024 | - | $1.27B(+17.1%) |
Mar 2024 | - | $1.09B(+14.1%) |
Dec 2023 | $952.20M(+4.0%) | $952.20M(-0.6%) |
Sep 2023 | - | $958.30M(+4.8%) |
Jun 2023 | - | $914.10M(-13.7%) |
Mar 2023 | - | $1.06B(+15.6%) |
Dec 2022 | $915.80M(+26.0%) | $915.80M(+27.1%) |
Sep 2022 | - | $720.40M(-1.8%) |
Jun 2022 | - | $733.60M(-4.1%) |
Mar 2022 | - | $764.70M(+5.2%) |
Dec 2021 | $727.00M(-12.4%) | $727.00M(-6.8%) |
Sep 2021 | - | $779.80M(-13.1%) |
Jun 2021 | - | $897.20M(+0.2%) |
Mar 2021 | - | $895.40M(+7.9%) |
Dec 2020 | $829.70M(+212.3%) | $829.70M(+52.0%) |
Sep 2020 | - | $545.90M(-4.8%) |
Jun 2020 | - | $573.20M(-30.8%) |
Mar 2020 | - | $827.90M(+211.6%) |
Dec 2019 | $265.70M(-59.1%) | $265.70M(-62.2%) |
Sep 2019 | - | $703.58M(+8.5%) |
Jun 2019 | - | $648.22M(+15.5%) |
Mar 2019 | - | $561.19M(-13.6%) |
Dec 2018 | $649.54M(+29.8%) | $649.54M(+151.8%) |
Sep 2018 | - | $257.99M(-49.0%) |
Jun 2018 | - | $505.92M(+8.3%) |
Mar 2018 | - | $467.25M(-6.6%) |
Dec 2017 | $500.49M(+78.7%) | $500.49M(-1.9%) |
Sep 2017 | - | $510.34M(+0.3%) |
Jun 2017 | - | $509.03M(+135.8%) |
Mar 2017 | - | $215.89M(-22.9%) |
Dec 2016 | $280.03M(-21.9%) | $280.03M(-15.5%) |
Sep 2016 | - | $331.23M(-9.3%) |
Jun 2016 | - | $365.07M(-3.3%) |
Mar 2016 | - | $377.71M(+5.4%) |
Dec 2015 | $358.36M(+96.3%) | $358.36M(-1.3%) |
Sep 2015 | - | $362.96M(-2.4%) |
Jun 2015 | - | $371.86M(-4.6%) |
Mar 2015 | - | $389.77M(+113.5%) |
Dec 2014 | $182.54M(+33.5%) | $182.54M(+7.5%) |
Sep 2014 | - | $169.82M(-8.5%) |
Jun 2014 | - | $185.52M(-12.1%) |
Mar 2014 | - | $211.13M(+54.4%) |
Dec 2013 | $136.76M(-21.2%) | $136.76M(-6.3%) |
Sep 2013 | - | $145.90M(+3.3%) |
Jun 2013 | - | $141.28M(-3.6%) |
Mar 2013 | - | $146.52M(-15.6%) |
Dec 2012 | $173.62M(+103.4%) | $173.62M(+12.1%) |
Sep 2012 | - | $154.91M(+1.8%) |
Jun 2012 | - | $152.11M(+2.5%) |
Mar 2012 | - | $148.34M(+73.8%) |
Dec 2011 | $85.37M(+6.3%) | $85.37M(-2.6%) |
Sep 2011 | - | $87.68M(+25.2%) |
Jun 2011 | - | $70.05M(-9.7%) |
Mar 2011 | - | $77.56M(-3.4%) |
Dec 2010 | $80.27M | $80.27M(+2.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $78.41M(-14.4%) |
Jun 2010 | - | $91.64M(+84.4%) |
Mar 2010 | - | $49.70M(+40.3%) |
Dec 2009 | $35.43M(-36.0%) | $35.43M(+3.7%) |
Sep 2009 | - | $34.15M(+64.4%) |
Jun 2009 | - | $20.77M(-40.1%) |
Mar 2009 | - | $34.67M(-37.3%) |
Dec 2008 | $55.33M(-63.8%) | $55.33M(-30.7%) |
Sep 2008 | - | $79.83M(-15.2%) |
Jun 2008 | - | $94.14M(-29.9%) |
Mar 2008 | - | $134.23M(-12.3%) |
Dec 2007 | $153.04M(-11.8%) | $153.04M(+41.5%) |
Sep 2007 | - | $108.16M(-17.8%) |
Jun 2007 | - | $131.65M(-13.7%) |
Mar 2007 | - | $152.49M(-12.1%) |
Dec 2006 | $173.54M(-29.3%) | $173.54M(-5.4%) |
Sep 2006 | - | $183.51M(-15.3%) |
Jun 2006 | - | $216.69M(-10.4%) |
Mar 2006 | - | $241.97M(-1.5%) |
Dec 2005 | $245.62M(-3.4%) | $245.62M(-6.5%) |
Sep 2005 | - | $262.59M(+13.6%) |
Jun 2005 | - | $231.23M(-1.1%) |
Mar 2005 | - | $233.85M(-8.0%) |
Dec 2004 | $254.23M(-29.7%) | $254.23M(-3.9%) |
Sep 2004 | - | $264.55M(-1.5%) |
Jun 2004 | - | $268.55M(-5.5%) |
Mar 2004 | - | $284.11M(-21.5%) |
Dec 2003 | $361.80M(+67.8%) | $361.80M(+3.6%) |
Sep 2003 | - | $349.10M(+64.1%) |
Jun 2003 | - | $212.69M(-13.1%) |
Mar 2003 | - | $244.72M(+13.5%) |
Dec 2002 | $215.62M(-29.7%) | $215.62M(-14.3%) |
Sep 2002 | - | $251.51M(-7.2%) |
Jun 2002 | - | $270.97M(-6.5%) |
Mar 2002 | - | $289.95M(-5.5%) |
Dec 2001 | $306.75M(+94.8%) | $306.75M(+118.7%) |
Sep 2001 | - | $140.26M(+3.1%) |
Jun 2001 | - | $135.99M(-7.4%) |
Mar 2001 | - | $146.79M(-6.8%) |
Dec 2000 | $157.45M(+82.7%) | $157.45M(+117.9%) |
Sep 2000 | - | $72.24M(-5.0%) |
Jun 2000 | - | $76.03M(-7.4%) |
Mar 2000 | - | $82.09M(-4.8%) |
Dec 1999 | $86.20M(+43.7%) | $86.20M(+75.2%) |
Sep 1999 | - | $49.20M(-6.8%) |
Jun 1999 | - | $52.80M(-6.9%) |
Mar 1999 | - | $56.70M(-5.5%) |
Dec 1998 | $60.00M(-13.5%) | $60.00M(-4.5%) |
Sep 1998 | - | $62.80M(-0.5%) |
Jun 1998 | - | $63.10M(-7.6%) |
Mar 1998 | - | $68.30M(-1.6%) |
Dec 1997 | $69.40M(+2.1%) | $69.40M(+1.8%) |
Sep 1997 | - | $68.20M(+1.6%) |
Jun 1997 | - | $67.10M(-6.5%) |
Mar 1997 | - | $71.80M(+5.6%) |
Dec 1996 | $68.00M | $68.00M(+6.9%) |
Sep 1996 | - | $63.60M(-2.2%) |
Jun 1996 | - | $65.00M(+199.5%) |
Mar 1996 | - | $21.70M |
FAQ
- What is Neurocrine Biosciences annual working capital?
- What is the all time high annual working capital for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual working capital year-on-year change?
- What is Neurocrine Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly working capital year-on-year change?
What is Neurocrine Biosciences annual working capital?
The current annual working capital of NBIX is $1.22B
What is the all time high annual working capital for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual working capital is $1.22B
What is Neurocrine Biosciences annual working capital year-on-year change?
Over the past year, NBIX annual working capital has changed by +$264.80M (+27.81%)
What is Neurocrine Biosciences quarterly working capital?
The current quarterly working capital of NBIX is $1.11B
What is the all time high quarterly working capital for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly working capital is $1.45B
What is Neurocrine Biosciences quarterly working capital year-on-year change?
Over the past year, NBIX quarterly working capital has changed by +$28.90M (+2.66%)